Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 21;21(14):5173.
doi: 10.3390/ijms21145173.

Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies

Lucía Melguizo-Rodríguez  1   2 , Victor J Costela-Ruiz  2   3 , Francisco Javier Manzano-Moreno  2   4 , Concepción Ruiz  2   3   5 , Rebeca Illescas-Montes  2   3
Affiliations
Review

Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies

Lucía Melguizo-Rodríguez et al. Int J Mol Sci. .

Abstract

Saliva is a highly versatile biological fluid that is easy to gather in a non-invasive manner-and the results of its analysis complement clinical and histopathological findings in the diagnosis of multiple diseases. The objective of this review was to offer an update on the contribution of salivary biomarkers to the diagnosis and prognosis of diseases of the oral cavity, including oral lichen planus, periodontitis, Sjögren's syndrome, oral leukoplakia, peri-implantitis, and medication-related osteonecrosis of the jaw. Salivary biomarkers such as interleukins, growth factors, enzymes, and other biomolecules have proven useful in the diagnosis and follow-up of these diseases, facilitating the early evaluation of malignization risk and the monitoring of disease progression and response to treatment. However, further studies are required to identify new biomarkers and verify their reported role in the diagnosis and/or prognosis of oral diseases.

Keywords: cytokines; diagnosis; oral pathology; salivary biomarker.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Wu J.Y., Yi C., Chung H.R., Wang D.J., Chang W.C., Lee S.Y., Lin C.T., Yang Y.C., Yang W.C.V. Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol. 2010;46:226–231. doi: 10.1016/j.oraloncology.2010.01.007. - DOI - PubMed
    1. Gaba F.I., Sheth C.C., Veses V. Salivary biomarkers and their efficacies as diagnostic tools for Oral Squamous Cell Carcinoma: Systematic review and meta-analysis. J. Oral Pathol. Med. 2018 doi: 10.1111/jop.12791. - DOI - PubMed
    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA A Cancer J. Clin. 2015;65:5–29. doi: 10.3322/caac.21254. - DOI - PubMed
    1. Saxena S., Sankhla B., Sundaragiri K.S., Bhargava A. A Review of Salivary Biomarker: A Tool for Early Oral Cancer Diagnosis. Adv. Biomed. Res. 2017;6:90. doi: 10.4103/2277-9175.211801. - DOI - PMC - PubMed
    1. Prasad G., McCullough M. Chemokines and Cytokines as Salivary Biomarkers for the Early Diagnosis of Oral Cancer. Int. J. Dent. 2013;2013:1–7. doi: 10.1155/2013/813756. - DOI - PMC - PubMed

MeSH terms